Active

Hildred Capital

Investor type

PE / VC

Founded

2018

AUM

$2 500 M

Location

New York City, New York, United States

Investment Ticket

$10-50 m

Investment Stage

Series B Late Stage (Series C+)

Region of investment

North America Europe
Investor profile last updated: 27 March, 2025

Profile

Hildred Capital is a New York based private equity firm focusing on the healthcare industry. Hildred pursues growth equity investments in lower middle market healthcare companies located in the U.S. and Canada with leading products, technologies and services. Hildred seeks opportunities to create value in healthcare companies with revenues of up to $100 million, from scaling businesses to generate earnings growth, promoting strategic and operational improvements, generating business development, and driving multiple expansion.

Industry

Financial Services Fintech Healthcare Services HealthTech Biotechnology Medical Devices Life Sciences

Hildred Capital Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
Hildred Equity Partners III
Private Equity (PE)
Biotechnology
Healthcare Services
Medical Devices
Life Sciences
Series B
Late Stage (Series C+)
North America
$5-10 m
$800 M
January 2025
Hildred Equity Partners II
Private Equity (PE)
Biotechnology
Healthcare Services
Medical Devices
Life Sciences
Series B
Late Stage (Series C+)
North America
$5-10 m
$363 M
February 2022

Contacts

Name
Title
Email
avatar
Kevin Hartz Co-founder
Co-founder
-
avatar
Bennett Siegel Co-founder
Co-founder
-
Upgrade to see contacts
avatar
PsgH7Mv80ZWlaLqm PsgH7Mv80ZWlaLqm
PsgH7Mv80ZWlaLqm
avatar
PsgH7Mv80ZWlaLqm PsgH7Mv80ZWlaLqm
PsgH7Mv80ZWlaLqm
avatar
PsgH7Mv80ZWlaLqm PsgH7Mv80ZWlaLqm
PsgH7Mv80ZWlaLqm
Investment-team contacts for Hildred Capital — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Hildred Capital

Hildred Capital is a venture capital and private equity firm. It backs companies at Series B and Late Stage (Series C+), writing tickets of $10-50 m.
Hildred Capital is located in New York City, New York, United States.
Hildred Capital was founded in 2018.
Hildred Capital invests in companies and startups in Financial Services, Fintech, Healthcare Services, HealthTech, Biotechnology, Medical Devices, Life Sciences.
Hildred Capital invests in companies and startups in North America, Europe.
Hildred Capital invests in companies and startups at Series B, Late Stage (Series C+).
Hildred Capital usually invests $10-50 m on average.
Hildred Capital has around $2 500m assets under management.
Hildred Capital last fund was created/launched in 2025-01-13
Hildred Capital can be reached through its website hildredcapital.com and its LinkedIn page. Its general enquiries address is info@hildredcapital.com. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Hildred Capital — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Hildred Capital directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 27 March, 2025. Something out of date here? Report it — we re-run that firm within 48h and get back to you.